Total liabilities · 2017–2025
Arcus Biosciences total liabilities
$508M−32.3% · FY2025
Arcus Biosciences (RCUS) reported $508M in total liabilities for fiscal 2025, −32.3% year on year.
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +38.9%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arcus Biosciences total liabilities |url=https://companiesranked.com/en/company/arcus-biosciences/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arcus Biosciences total liabilities. CompaniesRanked. https://companiesranked.com/en/company/arcus-biosciences/total-liabilitiesBibTeX
@misc{companiesranked-en-company-arcus-biosciences-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Arcus Biosciences total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arcus-biosciences/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001724521-26-000044 · August 5, 2026
{{cite web |title=Arcus Biosciences total liabilities — 10-Q (0001724521-26-000044) |url=https://www.sec.gov/Archives/edgar/data/1724521/000172452126000044/rcus-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.